Were the Ravens your starting fantasy football defense? Does your regular starter have a bye or a bad matchup and you’re ...

San Francisco 49ers team reporter Briana Jeannel addresses fans’ biggest questions ahead of Week 8 vs. the Houston Texans.

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Share on Pinterest A new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty Images Researchers say ...

Just in time for respiratory virus season, a highly transmissible COVID-19 strain is fueling a wave of infections across the US. The XFG variant, informally known as “Stratus,” has been driving up ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Eric Lefkofsky, founder of Groupon and Tempus AI, paid ...

KNOXVILLE, Tenn. (WATE) — UT-Battelle agreed to pay more than $2.8 million to employees after a lawsuit over COVID-19 vaccine requirements, said the U.S. Equal Employment Opportunity Commission (EEOC) ...

With fall, and by extension, respiratory illness season, underway, COVID-19 cases have continued to fluctuate nationwide. Some regions of the United States are experiencing "very high" and "high" ...

If you click on links we provide, we may receive compensation. Look good and feel even better when you land Amazon (3) If you're like me, you want to step off a long flight looking effortlessly ...

CHARLOTTESVILLE, Va. (WRIC) — Nineteen people were injured after a Friday night football game at Scott Stadium in Charlottesville, where Virginia pulled off a historic win over Florida State, a ...

Now that the Snapdragon 8 Elite Gen 5 has been announced, it’s time to start comparing it to the latest and greatest chips on the market. And its biggest competitor isn’t MediaTek – though you can ...

CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...